Inspire Medical Systems (INSP) shares new investor presentation and press release

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. filed a current report describing upcoming investor and analyst meetings in October 2025. The company is using a prepared slide presentation for these meetings, which is furnished as Exhibit 99.2 and made available on its investor relations website.

The filing also lists a related press release as Exhibit 99.1. The company clarifies that the presentation materials and related disclosure are furnished, not filed, so they are not subject to certain Exchange Act liability provisions or automatically incorporated into other securities law filings.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001609550False00016095502025-10-102025-10-10

SECURITIES AND EXCHANGE

Washington, D.C. 20549

_________________________

FORM 8-K

_________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): October 10, 2025

_________________________

INSPIRE MEDICAL SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

_________________________

Delaware

001-38468

26-1377674

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

5500 Wayzata Blvd., Suite 1600

Golden Valley, Minnesota 55416

(Address of principal executive offices) (Zip Code)

(844) 672-4357

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value per share

INSP

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company     ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition

period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

In October 2025, the Company will be participating in various meetings with investors and analysts, and a copy of the Company’s presentation materials being used at these meetings is furnished as Exhibit 99.2 hereto and is incorporated herein by reference. These presentation materials are also available on the Investor Relations page of the Company’s website at https://investors.inspiresleep.com.

The information in Item 7.01 of this Current Report on Form 8-K and the presentation attached as Exhibit 99.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01.    Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.						Description
99.1						Press release of Inspire Medical Systems, Inc., dated October 10, 2025.
99.2						Inspire Medical Systems, Inc. Presentation, October 10, 2025.
104						Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						INSPIRE MEDICAL SYSTEMS, INC.
Date:			October 10, 2025			By:			/s/ Bryan K. Phillips
									Bryan K. Phillips
									Sr. Vice President, General Counsel and Secretary

3

FAQ

What did Inspire Medical Systems (INSP) disclose in this 8-K filing?

Inspire Medical Systems disclosed that it will participate in investor and analyst meetings in October 2025. The company is using a prepared presentation for these meetings, furnished as Exhibit 99.2 and available on its investor relations website for broader access by interested stakeholders.

What exhibits are included in Inspire Medical Systems’ October 10, 2025 Form 8-K?

The filing includes three exhibits: a press release dated October 10, 2025 (Exhibit 99.1), an investor presentation dated October 10, 2025 (Exhibit 99.2), and the cover page interactive data file with embedded Inline XBRL tags (Exhibit 104), supporting electronic reporting requirements.

Where can investors find Inspire Medical Systems’ October 2025 presentation materials?

Investors can access the October 2025 presentation materials on Inspire Medical Systems’ investor relations website at https://investors.inspiresleep.com. The same presentation is also furnished as Exhibit 99.2 to the Form 8-K, ensuring consistent information across public channels.

Are Inspire Medical Systems’ October 2025 presentation materials considered filed with the SEC?

No, the company states that the information in Item 7.01 and Exhibit 99.2 is furnished, not filed, under the Exchange Act. This means it is not subject to Section 18 liability and is not incorporated into other filings unless specifically referenced.

Does this Inspire Medical Systems (INSP) 8-K announce any major transaction or earnings results?

The 8-K does not announce a major transaction or earnings results. It primarily addresses Regulation FD disclosure related to investor and analyst meetings and furnishes a press release and investor presentation as exhibits for informational purposes.